IVIG Dosing for Hand, Foot, and Mouth Disease (HFMD)
For severe HFMD in children, administer intravenous immunoglobulin (IVIG) at a dose of 1-2 g/kg body weight, typically given as 1 g/kg per day over 2 consecutive days. This recommendation is based on the most recent guideline evidence for severe pediatric viral illness requiring immunomodulation 1.
Dosing Regimen
The standard IVIG dose for severe HFMD is:
- Total dose: 1-2 g/kg based on ideal body weight
- Administration schedule: 1 g/kg on day 1 and 1 g/kg on day 2 (divided over 2 consecutive days)
- Infusion duration: Over 2 hours per dose 2
This dosing parallels the approach used for other severe pediatric inflammatory conditions like MIS-C, where IVIG 2 g/kg is standard first-line therapy 1.
When to Use IVIG in HFMD
IVIG should be considered specifically for severe or complicated HFMD cases, not mild disease 3. Indicators for severe disease requiring IVIG include:
- Persistent hyperthermia despite supportive care
- Neurological involvement (altered mental status, encephalopathy, meningismus)
- Circulatory dysfunction or myocardial impairment
- Respiratory compromise or neurogenic pulmonary edema
- Elevated inflammatory markers (CRP, CK, CK-MB)
- Children under 3 years with EV-A71 infection 4, 5
Clinical evidence supports early IVIG administration reduces serum inflammatory markers (CRP, CK, CK-MB) and improves clinical outcomes in severe HFMD 5. In one study, early IVIG achieved a 92.9% clinical effectiveness rate versus 80.0% with routine treatment alone.
Important Caveats
- Check serum IgA levels before administration - IgA deficiency can cause severe anaphylaxis; use IgA-depleted preparations if deficient 6
- Assess cardiac function and fluid status before infusion - particularly important in HFMD with potential myocardial involvement 1
- For doses >80 g, consider dividing over 3-5 days at 0.4 g/kg/day to reduce infusion-related complications 6
- Start infusion slowly at 0.01 mL/kg/min (0.5 mg/kg/min), increasing to maximum 0.10 mL/kg/min (5 mg/kg/min) if tolerated 7
Contraindications to Standard Dosing
In children with cardiac dysfunction from severe HFMD, divide the 2 g/kg dose over 2 days (1 g/kg daily) rather than single infusion to avoid volume overload 1. Monitor vital signs continuously during infusion and slow or stop if adverse reactions occur.
Vaccination Considerations
Defer measles, mumps, and varicella immunizations for 11 months after high-dose IVIG due to passive antibody transfer that may impair vaccine response 8, 7.
Context: Most HFMD Does Not Require IVIG
The vast majority of HFMD cases are mild and self-limited, resolving in 7-10 days with supportive care only 4, 9, 3. IVIG is reserved exclusively for severe cases with organ-threatening complications, particularly those caused by EV-A71 with neurological or cardiac involvement. Active monitoring and early recognition of deterioration are more critical than routine immunoglobulin therapy 9.